Food and Drug Administration's proposed approach to regulation of hematopoietic stem/progenitor cell products for therapeutic use.
Harvath
L
L
Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA.
D005312:Fetal Blood / Q000166:cytology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006412:Hematopoietic Stem Cells; D006801:Humans; D007883:Legislation, Medical; D013812:Therapeutics; D014481:United States; D014486:United States Food and Drug Administration